Stable silencing of ROR1 regulates cell cycle, apoptosis, and autophagy in a lung adenocarcinoma cell line.

ROR1 apoptosis autophagy cell cycle lung adenocarcinoma

Journal

International journal of clinical and experimental pathology
ISSN: 1936-2625
Titre abrégé: Int J Clin Exp Pathol
Pays: United States
ID NLM: 101480565

Informations de publication

Date de publication:
2020
Historique:
received: 09 03 2020
accepted: 14 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Lung cancer has the highest mortality and recurrence rate among cancers in the world. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) has been widely recognized for its role in promoting the growth and metastasis of lung cancer, but its comprehensive role and molecular mechanisms in regulating cell cycle, apoptosis, and autophagy remain unclear. In this study, a series of ROR1-stably silenced monoclonal clones from lung adenocarcinoma cell lines PC9, PC9erlo, and NCI-H1975 were successfully selected and confirmed by qRT-PCR, western blot, and flow cytometry, and used as cell models in the following assays. Our study clearly shows that blocking ROR1 significantly downregulates cell cycle-inducing molecules such as CDK4 and Cyclin E1, and anti-apoptotic molecules such as Bcl-XL and Bcl-2, while it markedly upregulates pro-apoptotic molecules such as Bak, Caspase-3, and Caspase-7, which extends our previous observation on the molecular mechanism of ROR1-mediated tumor growth in lung adenocarcinoma. Our data also show that silencing ROR1 promotes autophagy since the key molecules involved in autophagy including ATG7, ATG12, BNIP3L, LC3A, LC3B, and NBS1 were up-regulated. We further screened key phosphokinase signaling pathways downstream of ROR1 in lung adenocarcinoma by a human phospho-kinase array. Our data indicate that blocking ROR1 could deactivate Akt, then activate GSK-3α/β by de-phosphorylation, and finally deactivate mTOR. In this way blocking ROR1 could effectively regulate the cell cycle, apoptosis, and autophagy in lung cancer.

Identifiants

pubmed: 32509086
pmc: PMC7270672

Types de publication

Journal Article

Langues

eng

Pagination

1108-1120

Informations de copyright

IJCEP Copyright © 2020.

Déclaration de conflit d'intérêts

None.

Références

J Biol Chem. 2004 Feb 13;279(7):5387-96
pubmed: 14645251
Genes Cells. 1999 Jan;4(1):41-56
pubmed: 10231392
Comput Struct Biotechnol J. 2019 May 23;17:661-674
pubmed: 31205619
Leukemia. 2017 Dec;31(12):2615-2622
pubmed: 28465529
J Biochem. 2005 Mar;137(3):381-6
pubmed: 15809340
Int J Mol Sci. 2017 May 18;18(5):
pubmed: 28524116
Nat Commun. 2016 Jan 04;7:10060
pubmed: 26725982
PLoS One. 2012;7(3):e31127
pubmed: 22403610
Circ Res. 2015 Jan 2;116(1):138-49
pubmed: 25552693
ACS Chem Biol. 2015 Dec 18;10(12):2680-6
pubmed: 26390342
Cell. 2019 Jan 10;176(1-2):11-42
pubmed: 30633901
J Cell Biochem. 2019 Nov;120(11):18871-18882
pubmed: 31218746
Int J Cancer. 2014 Nov 15;135(10):2305-16
pubmed: 24706440
Cancer Cell. 2012 Mar 20;21(3):348-61
pubmed: 22439932
Cancers (Basel). 2019 May 24;11(5):
pubmed: 31137681
Oncol Lett. 2019 Sep;18(3):2977-2984
pubmed: 31452776
J Cell Mol Med. 2019 Aug;23(8):5282-5291
pubmed: 31199581
Cancer Cell. 2012 Nov 13;22(5):656-67
pubmed: 23153538
Cell Oncol (Dordr). 2017 Oct;40(5):419-441
pubmed: 28921309
Sci Rep. 2016 Nov 10;6:36447
pubmed: 27830754
PLoS One. 2011;6(6):e21018
pubmed: 21698301
Protein Cell. 2014 Jul;5(7):496-502
pubmed: 24752542
Blood. 2019 Aug 1;134(5):432-444
pubmed: 31151986
Oncotarget. 2017 May 16;8(20):32864-32872
pubmed: 28427197
Br J Clin Pharmacol. 2016 Nov;82(5):1245-1266
pubmed: 26469771
PLoS One. 2013 Apr 08;8(4):e61167
pubmed: 23593420
Cancer Discov. 2013 Dec;3(12):1378-93
pubmed: 24104062
Cancer Res Treat. 2017 Apr;49(2):330-337
pubmed: 27456943
Leuk Lymphoma. 2018 Jun;59(6):1439-1450
pubmed: 28918692
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10699-704
pubmed: 9380698
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17266-71
pubmed: 25411317
PLoS One. 2015 May 15;10(5):e0127092
pubmed: 25978653
World J Radiol. 2019 Mar 28;11(3):46-54
pubmed: 30949299
Cell Death Dis. 2018 Oct 23;9(11):1087
pubmed: 30352996
Int J Nanomedicine. 2019 Apr 24;14:2879-2902
pubmed: 31118613
J Virol. 2017 Jul 12;91(15):
pubmed: 28515304
Cancer Biol Ther. 2015;16(7):1005-13
pubmed: 25985143
PLoS One. 2018 Jun 1;13(6):e0198038
pubmed: 29856777
Stem Cell Res Ther. 2018 Nov 28;9(1):330
pubmed: 30486857
Int J Biol Sci. 2016 Nov 24;12(12):1461-1471
pubmed: 27994511
Essays Biochem. 2017 Dec 12;61(6):699-710
pubmed: 29233879
ACS Chem Biol. 2018 Aug 17;13(8):2247-2260
pubmed: 29878747
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
J Exp Clin Cancer Res. 2019 Mar 15;38(1):129
pubmed: 30876460
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1370-1377
pubmed: 30622177
Nat Immunol. 2009 May;10(5):461-70
pubmed: 19381141

Auteurs

Qi Zhou (Q)

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine Chengdu 611137, Sichuan, P. R. China.

Shiyi Zhou (S)

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine Chengdu 611137, Sichuan, P. R. China.

Huili Wang (H)

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine Chengdu 611137, Sichuan, P. R. China.

Yanping Li (Y)

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine Chengdu 611137, Sichuan, P. R. China.

Xiaoqian Xiao (X)

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine Chengdu 611137, Sichuan, P. R. China.

Jiahui Yang (J)

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine Chengdu 611137, Sichuan, P. R. China.

Classifications MeSH